Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients

[1]  K. Ding,et al.  DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma , 2020, Oncogene.

[2]  C. López-Camarillo,et al.  Evaluation of a panel of tumor-associated antigens in breast cancer. , 2019, Cancer biomarkers : section A of Disease markers.

[3]  M. Sherman,et al.  Epidemiologic risk factors for in situ and invasive ductal breast cancer among regularly screened postmenopausal women by grade in the Cancer Prevention Study-II Nutrition Cohort , 2019, Cancer Causes and Control.

[4]  C. Solinas,et al.  Breast cancer vaccines: Heeding the lessons of the past to guide a path forward. , 2019, Cancer treatment reviews.

[5]  Hailing Lu,et al.  Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets. , 2019, Vaccine.

[6]  S. Hanash,et al.  Whole Genome-Derived Tiled Peptide Arrays Detect Prediagnostic Autoantibody Signatures in Non-Small-Cell Lung Cancer. , 2019, Cancer research.

[7]  Elizabeth A Morris,et al.  Calcifications at Digital Breast Tomosynthesis: Imaging Features and Biopsy Techniques. , 2019, Radiographics : a review publication of the Radiological Society of North America, Inc.

[8]  M. Kerin,et al.  Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options , 2018, BMC Cancer.

[9]  I. Pastan,et al.  Cancer vaccine strategies: translation from mice to human clinical trials , 2018, Cancer Immunology, Immunotherapy.

[10]  V. Filonenko,et al.  Panel of SEREX-defined antigens for breast cancer autoantibodies profile detection , 2017, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[11]  Nicolai J. Birkbak,et al.  Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade , 2016, Science.

[12]  J. Manson,et al.  An Autoimmune Response Signature Associated with the Development of Triple-Negative Breast Cancer Reflects Disease Pathogenesis. , 2015, Cancer research.

[13]  R. Vierkant,et al.  Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study , 2015, Breast Cancer Research and Treatment.

[14]  M. Disis,et al.  Designing vaccines to prevent breast cancer recurrence or invasive disease. , 2015, Immunotherapy.

[15]  P. Treuting,et al.  Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor models , 2014, Breast Cancer Research and Treatment.

[16]  S. Hanash,et al.  Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer , 2014, Journal of Translational Medicine.

[17]  Derek C. Radisky,et al.  Understanding the Premalignant Potential of Atypical Hyperplasia through Its Natural History: A Longitudinal Cohort Study , 2014, Cancer Prevention Research.

[18]  Yuchen Jiao,et al.  Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer , 2014, Science.

[19]  S. Hanash,et al.  Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women. , 2013, Cancer research.

[20]  M. Beckmann,et al.  Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis , 2012, BMC Cancer.

[21]  S. Hanash,et al.  Evaluation of Known Oncoantibodies, HER2, p53, and Cyclin B1, in Prediagnostic Breast Cancer Sera , 2012, Cancer Prevention Research.

[22]  Aaron N. Chang,et al.  Functional genomics identifies therapeutic targets for MYC-driven cancer , 2012, Proceedings of the National Academy of Sciences.

[23]  E. Mardis,et al.  Cancer Exome Analysis Reveals a T Cell Dependent Mechanism of Cancer Immunoediting , 2012, Nature.

[24]  N. Yoo,et al.  Frameshift mutations of vacuolar protein sorting genes in gastric and colorectal cancers with microsatellite instability. , 2012, Human pathology.

[25]  D. Sgroi,et al.  The molecular pathology of breast cancer progression , 2011, The Journal of pathology.

[26]  J. Solassol,et al.  Humoral response to cancer as a tool for biomarker discovery. , 2009, Journal of proteomics.

[27]  P. Rouanet,et al.  Identification of a New Panel of Serum Autoantibodies Associated with the Presence of In situ Carcinoma of the Breast in Younger Women , 2009, Clinical Cancer Research.

[28]  B. Walker,et al.  Immunodominant HIV-1 Cd4+ T Cell Epitopes in Chronic Untreated Clade C HIV-1 Infection , 2009, PloS one.

[29]  M. Disis,et al.  Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer. , 2008, Cancer research.

[30]  C. Denkert,et al.  Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression. , 2007, Gynecologic oncology.

[31]  C. Morris,et al.  Cytokeratin KRT8/18 expression differentiates distinct subtypes of grade 3 invasive ductal carcinoma of the breast. , 2007, Cancer genetics and cytogenetics.

[32]  P. Schultz,et al.  In vivo selection for metastasis promoting genes in the mouse , 2007, Proceedings of the National Academy of Sciences.

[33]  Zhiyuan Hu,et al.  Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors , 2007, Genome Biology.

[34]  Hailing Lu,et al.  The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigens. , 2006, Cancer research.

[35]  Hailing Lu,et al.  Immunoediting of Cancers May Lead to Epithelial to Mesenchymal Transition1 , 2006, The Journal of Immunology.

[36]  R. Schreiber,et al.  The immunobiology of cancer immunosurveillance and immunoediting. , 2004, Immunity.

[37]  David E. Misek,et al.  Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. , 2004, Journal of proteome research.

[38]  Jeffrey E. Green,et al.  Development and Characterization of a Progressive Series of Mammary Adenocarcinoma Cell Lines Derived from the C3(1)/SV40 Large T-antigen Transgenic Mouse Model , 2004, Breast Cancer Research and Treatment.

[39]  E. Tan.  Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. , 2001, The Journal of clinical investigation.

[40]  R. Zinkernagel,et al.  Interferon gamma-producing gammadelta T cell-dependent antibody isotype switching in the absence of germinal center formation during virus infection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Green,et al.  Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Cardiff,et al.  Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.